The Role of Vitamin E Incorporated Oat Supplementation in Metabolic Syndrome (MetS) Patients

The objective of this study is to evaluate the effect of vitamin E incorporated oat supplementation among the metabolic syndrome (MetS) patients.

Inclusion Criteria:Age 18 years old and aboveIndividuals who have been identified as having metabolic syndrome (meet ≥3 out of 5 NCEP-ATP III Criteria)Stable weight (± 2 kg during the past 3months) to ensure reliable weight changes with the treatment given.Not taking antioxidant/anti-inflammatory supplements (Example of antioxidant: vitamin C, vitamin E, grape seed extract, garlic capsule, ginkgo biloba); (Example of the anti-inflammatory supplement: fish oil, curcumin extract, ginger extract, spirulina)Exclusion Criteria:Having liver (chronic liver failure, cirrhosis, all types of hepatitis), kidney (chronic kidney disease, haemodialysis) or haematological (anaemia, thalassemia, haemophilia) disordersCancer (all types) and endocrine disorders (Cushing's disease, gigantism and hyperthyroidism).Alcohol and drug abuse (self-mentioned or as recorded in the medical card)Hormone replacement therapy (for at least three months prior to entering the study)Use of steroids, chemotherapy, immunosuppressant, or radiotherapyCurrently pregnant or lactatingParticipations currently under another supplementary program